Raymond James & Associates’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$493K	Sell	52,456 -7,463	-12%	-$70.7K	﹤0.01%	3121
2024 Q2	$481K	Sell	59,919 -7,371	-11%	-$79K	﹤0.01%	3104
2024 Q1	$997K	Buy	67,290 +50,380	+298%	+$586K	﹤0.01%	2593
2023 Q4	$137K	Buy	16,910 +3,868	+30%	+$20.2K	﹤0.01%	3596
2023 Q3	$59.3K	Buy	13,042 +125	+1%	+$816	﹤0.01%	3663
2023 Q2	$90.9K	Buy	12,917 +2,700	+26%	+$19.3K	﹤0.01%	3648
2023 Q1	$62.4K	Buy	+10,217	New	+$70.5K	﹤0.01%	3712
2022 Q4	–	Sell	-19,863	Closed	-$190K	–	3992
2022 Q3	$190K	Buy	19,863 +50	+0.3%	+$577	﹤0.01%	3464
2022 Q2	$219K	Buy	19,813 +4,427	+29%	+$58K	﹤0.01%	3446
2022 Q1	$256K	Buy	15,386 +5,350	+53%	+$82.7K	﹤0.01%	3518
2021 Q4	$192K	Buy	10,036 +1,797	+22%	+$39.6K	﹤0.01%	3715
2021 Q3	$203K	Sell	8,239 -8,726	-51%	-$206K	﹤0.01%	3661
2021 Q2	$441K	Sell	16,965 -2,480	-13%	-$64.5K	﹤0.01%	3178
2021 Q1	$616K	Sell	19,445 -1,853	-9%	-$76.8K	﹤0.01%	2867
2020 Q4	$988K	Sell	21,298 -26,151	-55%	-$1.04M	﹤0.01%	2357
2020 Q3	$1.56M	Buy	47,449 +6,521	+16%	+$200K	﹤0.01%	1912
2020 Q2	$1.12M	Buy	40,928 +50	+0.1%	+$1.64K	﹤0.01%	2084
2020 Q1	$1.22M	Buy	40,878 +27,354	+202%	+$725K	﹤0.01%	1851
2019 Q4	$374K	Sell	13,524 -988	-7%	-$22.5K	﹤0.01%	2946
2019 Q3	$264K	Sell	14,512 -4,281	-23%	-$94.7K	﹤0.01%	3087
2019 Q2	$461K	Buy	+18,793	New	+$283K	﹤0.01%	2739
2018 Q3	–	Sell	-52,856	Closed	-$677K	–	3680
2018 Q2	$677K	Buy	52,856 +883	+2%	+$12.9K	﹤0.01%	2479
2018 Q1	$878K	Buy	+51,973	New	+$787K	﹤0.01%	2226
2016 Q2	–	Sell	-13,700	Closed	-$70K	–	3061
2016 Q1	$70K	Buy	+13,700	New	+$75K	﹤0.01%	2760